Business ❯ Corporate Governance

Regulatory Compliance

Securities Regulation Securities and Exchange Commission Antitrust Issues EU Regulations Financial Regulations Fines and Penalties Market Competition Financial Reporting Investigations Environmental Regulations

Biogen to Buy RayThera for Up to $1 Billion

The acquisition adds small-molecule anti-inflammatory candidates to Biogen’s pipeline with most payments tied to clinical and regulatory milestones.

iRhythm Confirms Patient Data Stolen in Cyberattack on Third-Party Apps

FTC Readies Complaint Over Amazon’s Use of Hidden Ad ‘Reserve’ Prices

Two Harbors Says UWM Failed to Submit Revised Offer and Urges Shareholders to Back CrossCountry

State Attorneys General Serve OpenAI With Sweeping Subpoena Over ChatGPT Safety

Securities Suit Filed Against ADMA Biologics After Short‑Seller Report

Kenneth Leech Pleads Guilty to Obstructing SEC Probe

Humacyte Prices $50 Million Stock Offering to Fund Symvess Push

Mississippi Residents File Class Action Against xAI and SpaceX Over 'Inescapable' Data‑Center Noise

SEC and CFTC End Longstanding No‑Deny Settlement Rules

Multiple Plaintiff Firms Press Investors to Lead FS KKR Capital Securities Lawsuit

CFTC Rescinds No‑Deny Settlement Policy

Orano and Cameco Agree to Buy TEPCO’s 5% Stake in Cigar Lake

SpaceX Flags Water Access as Material Risk in Amended IPO Filing

MiniMax Begins Preparations for Shanghai Star Market Listing

ASIC Seeks A$2.4m in Fines as Court Weighs Long Bans for Ex‑Star Executives

Apple Asks New Jersey Court to Compel 14 Federal Agencies to Hand Over Documents in DOJ Antitrust Suit

SEC Rescinds Decades‑Old ‘No‑Deny’ Settlement Rule

Volvo Group Reaches $196.5 Million CARB Settlement Over 2010–2016 Truck Engines

Delhi High Court Orders Apple to Cooperate in India App Store Antitrust Probe